Understanding Immune Thrombocytopenia: Looking Out of the Box

The pathogenesis of immune thrombocytopenia (ITP) is increasingly being elucidated, and its etiology is becoming more frequently identified, leading to a diagnostic shift from primary to secondary ITP. The overlap between autoimmunity, immunodeficiency, and cancer is evident, implying more interdisciplinarity in daily care. This mini-review is based on an expert meeting on ITP organized by the Intercontinental Cooperative ITP Study Group and presents the challenges of hematologists in understanding and investigating “out of the box” concepts associated with ITP.

Abstract licence: CC BY

1. 33.

   Cancers Related to Immunodeficiencies: Update and Perspectives · 2016

2. 35.

   Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover · 2016

3. 39.

   Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP) · 2017

4. 53.

   Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance · 2018

57 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.